Rubicon Research Limited
Bajaj Finserv Mutual Fund increased its stake in Rubicon Research Limited from 1.22% to 1.33%, increasing its shareholding from 2,016,210 shares to 2,191,575 shares. The value of the additional shares bought was ₹27.8 Cr at an average price of ₹1500.80 per share.
A pharmaceutical company engaged in the development, manufacturing, and commercialization of differentiated drug formulations across multiple therapeutic areas. Incorporated in 1999, the company specializes in creating specialized formulations that address specific medical needs in the Indian healthcare market. Its integrated operations span research and development, manufacturing of quality pharmaceuticals, and distribution. The company distinguishes itself through its focus on bringing innovative, differentiated solutions to patients and healthcare providers.
AMC subsidiary of Bajaj Finserv, India's leading non-banking financial services conglomerate. Launched in 2023 with an aggressive passive-first strategy, offering index funds and ETFs at competitive expense ratios to challenge incumbents in the rapidly growing passive segment. One of the fastest-growing new entrants in the AMC space with strong distribution from Bajaj Finserv's vast financial services network.